Literature DB >> 23475159

Tenascin C and its modulatory role in tumor progression in systemic malignancies.

Shailendra Kapoor1.   

Abstract

Entities:  

Year:  2013        PMID： 23475159      PMCID： PMC3967620          DOI： 10.1007/s10616-013-9552-8

Source DB:  PubMed          Journal:  Cytotechnology        ISSN： 0920-9069            Impact factor:   2.058


× No keyword cloud information.
  9 in total

1.  Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells.

Authors:  Keiki Nagaharu; Xinhui Zhang; Toshimichi Yoshida; Daisuke Katoh; Noriko Hanamura; Yuji Kozuka; Tomoko Ogawa; Taizo Shiraishi; Kyoko Imanaka-Yoshida
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs.

Authors:  Thordur Oskarsson; Swarnali Acharyya; Xiang H-F Zhang; Sakari Vanharanta; Sohail F Tavazoie; Patrick G Morris; Robert J Downey; Katia Manova-Todorova; Edi Brogi; Joan Massagué
Journal:  Nat Med       Date:  2011-06-26       Impact factor: 53.440

3.  Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1.

Authors:  Ilunga Kalembeyi; Hiroyasu Inada; Rika Nishiura; Kyoko Imanaka-Yoshida; Teruyo Sakakura; Toshimichi Yoshida
Journal:  Int J Cancer       Date:  2003-05-20       Impact factor: 7.396

4.  Clinical significance of large tenascin-C spliced variant as a potential biomarker for colorectal cancer.

Authors:  Akihiko Takeda; Yoshihide Otani; Hiroyoshi Iseki; Hideki Takeuchi; Kimiyasu Aikawa; Satoru Tabuchi; Nozomi Shinozuka; Toshiaki Saeki; Yasushi Okazaki; Isamu Koyama
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

5.  Expression of scleraxis and tenascin C in equine adipose and umbilical cord blood derived stem cells is dependent upon substrata and FGF supplementation.

Authors:  Sarah A Reed; Sally E Johnson
Journal:  Cytotechnology       Date:  2013-01-09       Impact factor: 2.058

6.  Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion.

Authors:  Kalembeyi Ilunga; Rika Nishiura; Hiroyasu Inada; Amro El-Karef; Kyoko Imanaka-Yoshida; Teruyo Sakakura; Toshimichi Yoshida
Journal:  Int J Exp Pathol       Date:  2004-12       Impact factor: 1.925

7.  Over-expression of 14-3-3sigma in budding colorectal cancer cells modulates cell migration in the presence of tenascin-C.

Authors:  Munenori Ide; Kana Saito; Soichi Tsutsumi; Kaori Tsuboi; Satoru Yamaguchi; Takayuki Asao; Hiroyuki Kuwano; Takashi Nakajima
Journal:  Oncol Rep       Date:  2007-12       Impact factor: 3.906

8.  Tenascin-C expression and its prognostic significance in colorectal cancer.

Authors:  M Lundin; S Nordling; J Lundin; C Haglund
Journal:  Oncology       Date:  2008-01-15       Impact factor: 2.935

9.  Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.

Authors:  Rachael A Hancox; Michael D Allen; Deborah L Holliday; Dylan R Edwards; Caroline J Pennington; David S Guttery; Jacqueline A Shaw; Rosemary A Walker; J Howard Pringle; J Louise Jones
Journal:  Breast Cancer Res       Date:  2009-04-30       Impact factor: 6.466
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.